Frontiers in Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-09-17 146e0980m70暂无昵称

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0
偏重的研究方向：肿瘤
经验分享：来还愿了
修回3天后审稿人全部endorse
第4天就直接accept了
从投稿到接收差不多两个月左右，这个速度简直感激

527 77

展开77条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-02-25 ms7000001464145733

请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌

196 41

展开41条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-09-09 凶巴巴恰北北怪兽

请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？

146 29

展开29条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-12-07 ms8000001015682516

偏重的研究方向：肿瘤
经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。

180 27

展开27条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-09-24 wwwlifei

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：乳腺癌
经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。

140 27

展开27条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-09-09 ms4000001638128877

审稿速度:1.0
偏重的研究方向：肿瘤;生信
经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。

133 25

展开25条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2022-04-15 156GRoK0535(apple)

偏重的研究方向：诊断;肿瘤;临床
经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸

183 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2020-08-13 seven 7

审稿速度:2.0 | 投稿命中率:50.0
经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。

299 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-11-24 lock-bb

投稿命中率:5.0
偏重的研究方向：肿瘤
经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的

150 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=1052409, encodeId=26df105240933, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2950.0 偏重的研究方向：肿瘤 经验分享：来还愿了 修回3天后审稿人全部endorse 第4天就直接accept了 从投稿到接收差不多两个月左右，这个速度简直感激, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=77, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Fri Sep 17 20:59:04 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927060, encodeId=bc6892e06078, content=请教一下，我的两个审稿人都 endorsed了，已经过去17天了，编辑还没给我发邮件，一直卡在 review finalized这，可以发邮件问问编辑么？现在好慌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cce25463015, createdName=ms7000001464145733, createdTime=Thu Feb 25 11:09:18 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016178, encodeId=032510161e8e9, content=请问各位，一个审稿人的意见回来了，给我发了邮件。是继续等其他人的意见吗？编辑不需要根据审稿人的意见决定修稿还是拒？就直接发邮件了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=29, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Sep 09 22:54:39 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077685, encodeId=09a910e768507, content=偏重的研究方向：肿瘤 经验分享：各位大神审稿人同意后一般多久接收啊，我俩审稿人都同意了，现在第四天还是在review finalized显示编辑在做决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2f55453269, createdName=ms8000001015682516, createdTime=Tue Dec 07 10:25:04 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054460, encodeId=b49a10544605c, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌 经验分享：两个审稿人，一个endorse,另一个reject，后面会怎么处理呢？担心、焦虑中。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96b51604536, createdName=wwwlifei, createdTime=Fri Sep 24 14:49:15 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016074, encodeId=c23710160e430, content=审稿速度:1.0 偏重的研究方向：肿瘤;生信 经验分享：为什么我特么2号提交的论文，不过1周的时间就回来三个reviewer, 还有一个reviewer在pending。已经出来的三个评审人最少的都给出了9条comment，每个人都有那么两条特别难缠。之前投一区的也没这么累啊。关键是累死累活，能不能中另说，中了也是一个不上台面的三区，真是日了狗了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=25, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=65c35586447, createdName=ms4000001638128877, createdTime=Thu Sep 09 15:50:22 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211496, encodeId=e8c012114967d, content=偏重的研究方向：诊断;肿瘤;临床 经验分享：接收了，好开心，感恩主编和审稿人😊！🌷🌹🌸, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202406/80984ecf602246ee81c409daab29bdc7-NEmwDYJZoM0d.jpg, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Fri Apr 15 17:58:36 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808424, encodeId=aba1808424f2, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：刚接收一篇，用时3+月，外科手术肿瘤方向，4.15投 5.1送外审 5.22收到两个审稿人的修改意见，给了20天修改时间，因为事情耽搁，7月21修回。1个审稿人第二天同意发表，另一个20天后同意发表，最后隔了一天收到接收信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f02532537, createdName=seven 7, createdTime=Thu Aug 13 13:05:27 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073498, encodeId=65ba10e3498cb, content=投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：我在independent review阶段已经3个月了期间也有review is ongoing 然后又消失但并没有看到任何的审稿意见现在一直是Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready。这种要去催编辑吗这个是因为没有审稿人吗我看大家很多没激活interactive的时候也看的到审稿意见的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a665577905, createdName=lock-bb, createdTime=Wed Nov 24 11:44:08 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975260, encodeId=5a249e526023, content=没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=893b2183302, createdName=佛应拉吾, createdTime=Sun Jun 20 22:40:41 CST 2021, time=2021-06-20, status=1, ipAttribution=)]

2021-06-20 佛应拉吾

没投过，但是现在出了太多的预测模型灌水文章，对不起其他做基础研究实验的，这个杂志不上预警期刊，天理不容。。。

195 20

展开20条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务